Selected Recent Articles
- FDA Approved Changes to the Genvoya Label. (September 2016, TheBodyPro)
- FDA Approved Changes to the Sustiva Label. (September 2016, TheBodyPro)
- FDA Approves Once-Daily Hepatitis C Regimen Viekira XR. (July 2016, Hepmag)
- FDA approves expanded Prezista label for pregnant women with HIV. (July 2016, Healio)
- FDA Approves Epclusa Combo Pill for All Types of Hepatitis C. (July 2016, Beta Blog); related coverage from NEJM Journal Watch
- FDA updates Prezista recommendations for pregnant women with HIV. (June 2016, Healio)
- Descovy, New HIV Drug Containing Tenofovir Alafenamide, Approved by FDA. (April 2016, TheBodyPRO); related coverage from Beta Blog, Healio, and Poz
- FDA to Place “Black Box” Warnings on All Prescription Opioids. (March 2016, Hepmag)
- FDA updates Complera label for use in children aged older than 12 years. (March, Healio)
- FDA OKs Gilead’s Genvoya, First HIV Combo Pill With New Tenofovir. (November 5, 2015, Poz)
- FDA Warns of Serious Liver Injury Risk with Hepatitis C Treatments Viekira Pak and Technivie. (October 2015, FDA and TheBodyPro)
- Cobicistat and elvitegravir approved in the U.S. as single pills. (September/October 2014, HIV Treatment Bulletin)
- Single-pill dolutegravir/abacavir/3TC (Triumeq) approved in EU and US. (September/October 2014, HIV Treatment Bulletin)
- New FDA HIV Drug Approvals Unlikely to Have Much Impact, Unless… (September 2014, Journal Watch)
- HIV/AIDS Update – Approval of Vitekta. (September 2014, U.S. Food and Drug Administration)
- HIV/AIDS Update: Approval of Tybost (cobicistat) 150 mg tablets. (September 2014, U.S. Food and Drug Administration)
- Tybost (Cobicistat) and Vitekta (Elvitegravir) Approved as Individual HIV Drugs. (September 2014, TheBody)
- FDA Approves Gilead’s Vitekta (Elvitegravir) to Treat HIV. (September 2014, Poz)
- FDA Approves HIV Treatment Boosting Agent Tybost (Cobicistat) (September 2014, Poz)
- FDA Approves New Single-Tablet HIV Regimen, Triumeq. (August 2014, Poz)
- FDA OKs Oral Isentress to Treat HIV in Children. (January 2014, Poz)
- Government Shutdown May Slow FDA Drug Approvals. (September 2013, Poz)
- FDA Approves HIV Drug Tivicay (Dolutegravir) (August 2013, Poz)
- FDA OKs First Rapid Test That Can Detect Acute HIV. (August 2013, Poz)
- FDA OKs Generic Truvada for Use Abroad. (August 2013, Poz)
- FDA Approves Sustiva for Children 3 Months to 3 Years Old. (May 2013, Poz)
- FDA Updates Atripla Label. (April 2013, Poz)
- FDA Approves Changes to Reyataz Label. (February 2013, Poz)
- FDA Releases Updated Drug Interaction Information for Kaletra. (February 2013, Poz)